search
Back to results

Investigation of Corneal Aberrations and Visual Outcomes in Patients Implanted With an AcrySof Toric Intraocular Lens (IOL)

Primary Purpose

Cataracts, Astigmatism

Status
Withdrawn
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Toric
Sponsored by
Alcon Research
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Cataracts focused on measuring Cataract, Toric IOL, Corneal Aberration, Astigmatism, AcrySof

Eligibility Criteria

18 Years - 70 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Operable cataracts;
  • Good ocular health;
  • Qualifies for AcrySof Toric IOL via AcrySof Toric Calculator (1.03-2.06 D cylinder at corneal plane)

Exclusion Criteria:

  • >2.06 D astigmatism at corneal plane;
  • irregular astigmatism;
  • prior or ongoing corneal disease or scarring;
  • history of ocular disease

Sites / Locations

    Arms of the Study

    Arm 1

    Arm Type

    Other

    Arm Label

    Toric

    Arm Description

    AcrySof Toric IOL to assess corneal aberration

    Outcomes

    Primary Outcome Measures

    Corneal Aberration

    Secondary Outcome Measures

    Visual acuity, residual refractive cylinder, lens alignment

    Full Information

    First Posted
    April 7, 2009
    Last Updated
    July 31, 2012
    Sponsor
    Alcon Research
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT00878839
    Brief Title
    Investigation of Corneal Aberrations and Visual Outcomes in Patients Implanted With an AcrySof Toric Intraocular Lens (IOL)
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    June 2012
    Overall Recruitment Status
    Withdrawn
    Why Stopped
    Product availability
    Study Start Date
    March 2009 (undefined)
    Primary Completion Date
    March 2009 (Actual)
    Study Completion Date
    March 2009 (Actual)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    Alcon Research

    4. Oversight

    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    A prospective evaluation of postoperative corneal aberrations and visual parameters (e.g. visual acuity) in patients implanted with an AcrySof Toric IOL.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Cataracts, Astigmatism
    Keywords
    Cataract, Toric IOL, Corneal Aberration, Astigmatism, AcrySof

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Not Applicable
    Interventional Study Model
    Single Group Assignment
    Masking
    None (Open Label)
    Allocation
    Non-Randomized
    Enrollment
    0 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    Toric
    Arm Type
    Other
    Arm Description
    AcrySof Toric IOL to assess corneal aberration
    Intervention Type
    Device
    Intervention Name(s)
    Toric
    Intervention Description
    AcrySof Toric IOL
    Primary Outcome Measure Information:
    Title
    Corneal Aberration
    Time Frame
    3 months
    Secondary Outcome Measure Information:
    Title
    Visual acuity, residual refractive cylinder, lens alignment
    Time Frame
    3 months

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Maximum Age & Unit of Time
    70 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Operable cataracts; Good ocular health; Qualifies for AcrySof Toric IOL via AcrySof Toric Calculator (1.03-2.06 D cylinder at corneal plane) Exclusion Criteria: >2.06 D astigmatism at corneal plane; irregular astigmatism; prior or ongoing corneal disease or scarring; history of ocular disease

    12. IPD Sharing Statement

    Learn more about this trial

    Investigation of Corneal Aberrations and Visual Outcomes in Patients Implanted With an AcrySof Toric Intraocular Lens (IOL)

    We'll reach out to this number within 24 hrs